Post-marketing oncology studies: Enabling faster recruitment and lower costs

In clinical trials, post-marketing approval studies remain a lower priority than other research areas, especially at community oncology centers. In clinical trials, post-marketing approval studies remain a lower priority than other research areas, especially at community oncology centers. Yet a pilot study has demonstrated the dramatic difference that effective health record to electronic data capture (EHR-to-EDC) solutions can make when supported by automation. Tech-enhanced patient screening also achieved the enrollment target more than twice as quickly as planned. Tech solutions are now enabling faster recruitment in clinical trials. Credit: via Shutterstock. Post-marketing approval studies in clinical research for cancer typically…

Source: Clinical Trials Arena